MACK
Merrimack Pharmaceuticals, Inc.
$15.14
%
Analyst Rating:Buy

Stock Details

CEO

Gary L. Crocker

Sector

Healthcare

Industry

Biotechnology

Full Time Employees

0

Address

One Broadway, Cambridge, MA, 02142

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Income Statement  

Financials

Selected Year

Revenue Estimates

EPS Estimates

Net Income Estimates

Price target for Merrimack Pharmaceuticals, Inc.  $15.14

EPS

Revenue

Congress Tracker 

Insider Trading of Key Employees

Financial News: MACK